资讯

BioMarin的收购要约已按计划于6月30日到期,约有45,455,118股有效交割,占Inozyme流通股份的约70%。在要约收购后,BioMarin通过其子公司Incline Merger Sub与Inozyme合并完成了收购。
The death toll is expected to rise as authorities search the rubble of a Sigachi Industries plant in the Indian state of ...
HYDERABAD, India -- The death toll from Monday's massive explosion and fire at a pharmaceutical factory in India’s southern ...
At least 36 people are dead and nearly three dozen are injured following an explosion at the Sigachi Industries chemical ...
Day SEC Yield of 2.11% as of June. 27. Payable Jul 07; for shareholders of record Jul 01; ex-div Jul 01. More on VanEck ...
Investor's Business Daily on MSN3 小时
Takeda Pharmaceutical ADR Earns RS Rating Upgrade
Takeda Pharmaceutical ADR shows improving price performance, earning an upgrade to its IBD Relative Strength Rating ...
An explosion and fire at a pharmaceutical factory in Telangana, India, have killed at least 12 people and injured several ...
To navigate the complexities of sophisticated drug development and manufacturing, a fundamental shift toward AI-powered ...
An explosion at a pharmaceutical factory near Hyderabad has left at least 35 people dead and dozens more injured. India's ...
加利福尼亚州诺瓦托 - 市值35亿美元、过去十二个月收入增长33%的生物制药公司Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE )周五宣布,其安格曼综合征治疗药物GTX-102(apazunersen)已获得美国食品药品监督管理局(FDA)的突破性疗法认定。根据 InvestingPro 分析,该公司目前的交易价格低于其公允价值,这表明投资者可能有上涨空间 ...
Ensuring the safety and quality of pharmaceuticals, such as blood products, vaccines, recombinant proteins, and monoclonal antibodies, is essential. Endotoxins act as a hidden ‘time bomb’ in these ...